Shareholders rebuke Bayer bosses over Monsanto-linked stock rout

Bayer shareholders on Friday cast a vote of disapproval of the German drugmaker’s top management amid anger over a stock price slump as litigation risks mount from the $63 billion takeover of seed maker Monsanto.